NEUREXPERT
LIVE

Serial Number

86650167

Owner

Neurexpert Ltd.

Attorney

Lisa Dunner

Filing Date

Jun 3, 2015

Add to watchlist:

No watchlists yet
View on USPTO

NEUREXPERT Trademark

Serial Number: 86650167 • Registration: 5010851

NEUREXPERT is a trademark filed by Neurexpert Ltd. on June 3, 2015. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Neurexpert Ltd.

Newcastle Upon Tyne NE4 5TF , GB

Entity Type: 99

Trademark Details

Filing Date

June 3, 2015

Registration Date

August 2, 2016

Published for Opposition

May 17, 2016

Goods & Services

Scientific and technological services and research and design relating thereto, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific analysis and research services, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific analysis and research services using cell cultures and/or stem cells to define the action of novel therapeutics in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services for electrophysiology and related techniques to define the action of novel therapeutics in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services providing data on biological, organic and non-organic chemical potency, efficacy and mechanism of action at a native biological target in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services measuring biological, organic and non-organic chemical compound potency against biological targets coupled to their native transduction pathways and expressed with their naturally occurring subunit conformation and accessory proteins in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services providing functional and mechanistic data on neural mechanisms that underlie higher brain functions, such as cognition, attention and sensory processing, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services to define the phenotype of transgenic models at the cellular and neuronal network level, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services to produce functional and mechanistic data on the physiological processes that may be affected in central nervous system disorders, such as the mechanisms underlying learning, memory, attention and sensory processing, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services for the provision of scientific functional and mechanistic data on neurophysiological diseases, including psychiatry, neurology, neurodegeneration, epilepsy, pain, ophthalmology and retinal neurodegeneration, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services for the provision of scientific functional and mechanistic data on biological targets, including ligand and voltage gated ion channels, G-protein coupled receptors and biological transporters, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory services to discover and research the biological site of action of novel therapeutics within a cellular and neuronal network, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of assays using cell cultures and/or stem cells, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of electrophysiology and electrophysiological assays, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of laboratory equipment assays using cell cultures and/or stem cells and laboratory consumables therefor, namely, for testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of laboratory equipment for electrophysiology and electrophysiological assays and laboratory consumables therefor, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific research consulting in the field of assays using and/or including cell cultures and/or stem cells; scientific research consulting in the field of electrophysiology and electrophysiological assays; scientific research consulting in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of educational and research project progression for all stages of the drug discovery process; scientific research consulting in the field of educational and research study plans in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of analysis and interpretation of experimental findings in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of the establishment and setting up of new laboratories; scientific research consulting in the field of the establishment and setting up of new laboratories using and/or including cell cultures and/or stem cells; scientific research consulting in the field of the establishment and setting up of new electrophysiology laboratories; scientific research consulting in the field of the design and development of assays for diseases and biological targets in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of the preparation of data for the pharmaceutical industry; scientific research consulting in the field of the preparation of data for the pharmaceutical industry generated from cell cultures and/or stem cells; scientific research consulting in the field of the preparation of electrophysiological data for the pharmaceutical industry; scientific research consulting in the field of the design and development of assays for drug discovery; scientific research consulting in the field of the design and development of assays using and/or including cell cultures and/or stem cells for drug discovery; scientific research consulting in the field of the design and development of electrophysiology assays for drug discovery; scientific research consulting in the field of assays and tests to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; scientific research consulting in the field of assays and tests using and/or including cell cultures and/or stem cells to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; scientific research consulting in the field of electrophysiology and electrophysiological assays and tests to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; scientific research consulting in the field of equipment purchase, and design and assembly of laboratories for in vitro and in vivo assays and tests; scientific research consulting in the field of equipment purchase, and design and assembly of laboratories using and/or including cell cultures and/or stem cells for in vitro assays and tests; scientific research consulting in the field of equipment purchase, and design and assembly of electrophysiology laboratories for in vitro and in vivo assays and tests; scientific research technology consulting services to the pharmaceutical industry on clinical and preclinical research in the fields of electrophysiology, neurophysiology and neuropharmacology; scientific research consulting services in neuroscience and translational research for disorders including neurology, neurodegeneration, psychiatry, epilepsy, pain and ophthalmology; scientific research technology consulting services providing guidance and experimental support for drug discovery research from target identification and validation through to candidate selection and progression to the clinic; scientific research consulting services on all applications of electrophysiology, including safety testing, drug screening, automated platforms and development of functional biomarkers

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 2, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 16, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 16, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 16, 2023 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 1, 2022 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 2, 2021 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 2, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 17, 2016 NPUB
PUBLISHED FOR OPPOSITION
May 17, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 27, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 13, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2016 CNSA
DATA MODIFICATION COMPLETED
Mar 12, 2016 DMCC
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 3, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2015 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2015 GNRT
NON-FINAL ACTION WRITTEN
Sep 22, 2015 CNRT
DATA MODIFICATION COMPLETED
Sep 15, 2015 DMCC
ASSIGNED TO LIE
Sep 15, 2015 ALIE
ASSIGNED TO EXAMINER
Sep 15, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2015 NWOS
NEW APPLICATION ENTERED
Jun 6, 2015 NWAP